Citigroup Inc Astrazeneca PLC Call Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $2.67 Million - $3.05 Million	34,800 Added 87.0%	74,800 $5.83 Million
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $2.44 Million - $2.78 Million	40,000 New	40,000 $2.71 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $8.1 Million - $8.96 Million	124,900 New	124,900 $8.46 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $6.48 Million - $7.66 Million	-120,000 Reduced 69.01%	53,880 $3.14 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $9.66 Million - $10.6 Million	173,880 New	173,880 $10.4 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.